Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
AI Summary
Novonesis is exploring gut-health supplements for people taking GLP-1 weight-loss drugs. The effort could create a new commercial opportunity as use of these medications grows.
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.